Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin
- 30 April 1992
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (3), 259-266
- https://doi.org/10.1016/0732-8893(92)90122-a
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humansJournal of Antimicrobial Chemotherapy, 1991
- Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humansAntimicrobial Agents and Chemotherapy, 1990
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Interpretative criteria for the agar diffusion susceptibility test with azithromycinJournal of Antimicrobial Chemotherapy, 1988
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- 14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human.The Journal of Antibiotics, 1988
- Disk diffusion and disk elution tests with A-56268 and erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibioticEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycinAntimicrobial Agents and Chemotherapy, 1987
- In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolideAntimicrobial Agents and Chemotherapy, 1986